These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 26826404)
1. Cytokeratin-positive interstitial reticulum cell tumor: recognition of a potential "in situ" pattern. Bösmüller H; Klenske J; Bonzheim I; Scharpf M; Rieger N; Quintanilla-Fend L; Fend F Hum Pathol; 2016 Mar; 49():15-21. PubMed ID: 26826404 [TBL] [Abstract][Full Text] [Related]
2. Cytokeratin-positive interstitial reticulum cell (CIRC) tumor in the lymph node: a case report of the transformation from the epithelioid cell type to the spindle cell type. Kaji S; Hiruta N; Sasai D; Nagashima M; Ohe R; Yamakawa M Diagn Pathol; 2020 Sep; 15(1):121. PubMed ID: 32979929 [TBL] [Abstract][Full Text] [Related]
3. Lymph node reticulum cell neoplasm with progression into cytokeratin-positive interstitial reticulum cell (CIRC) sarcoma: a case study. Lucioni M; Boveri E; Rosso R; Benazzo M; Necchi V; Danova M; Incardona P; Franco C; Viglio A; Riboni R; Lazzarino M; Magrini U; Canevari A; Paulli M Histopathology; 2003 Dec; 43(6):583-91. PubMed ID: 14636259 [TBL] [Abstract][Full Text] [Related]
4. Cytokeratin-positive fibroblastic reticular cell: a pitfall for dermatopathologists assessing lymph nodes for Merkel cell carcinoma. Olson NJ; Perry AE; Linos K J Cutan Pathol; 2016 Dec; 43(12):1231-1233. PubMed ID: 27640340 [No Abstract] [Full Text] [Related]
5. Increased numbers of cytokeratin-positive interstitial reticulum cells (CIRC) in reactive, inflammatory and neoplastic lymphadenopathies: hyperplasia or induced expression? Gould VE; Bloom KJ; Franke WW; Warren WH; Moll R Virchows Arch; 1995; 425(6):617-29. PubMed ID: 7535166 [TBL] [Abstract][Full Text] [Related]
6. Cytokeratin-positive malignant tumors with reticulum cell morphology: a subtype of fibroblastic reticulum cell neoplasm? Chan AC; Serrano-Olmo J; Erlandson RA; Rosai J Am J Surg Pathol; 2000 Jan; 24(1):107-16. PubMed ID: 10632494 [TBL] [Abstract][Full Text] [Related]
7. Cytokeratin-positive interstitial cell neoplasm: a case report and classification issues. Schuerfeld K; Lazzi S; De Santi MM; Gozzetti A; Leoncini L; Pileri SA Histopathology; 2003 Nov; 43(5):491-4. PubMed ID: 14636276 [TBL] [Abstract][Full Text] [Related]
8. Cytokeratin-positive fibroblastic reticular cell tumor with follicular dendritic cell features: a case report and review of the literature. Goto N; Tsurumi H; Takami T; Futamura M; Morimitsu K; Takata K; Sato Y; Yoshino T; Adachi S; Saito K; Yamakawa M Am J Surg Pathol; 2015 Apr; 39(4):573-80. PubMed ID: 25768257 [TBL] [Abstract][Full Text] [Related]
11. Intraparotid classical and nodular lymphocyte-predominant Hodgkin lymphoma: pattern analysis with emphasis on associated lymphadenoma-like proliferations. Agaimy A; Wild V; Märkl B; Wachter DL; Hartmann A; Rosenwald A; Ihrler S Am J Surg Pathol; 2015 Sep; 39(9):1206-12. PubMed ID: 25929348 [TBL] [Abstract][Full Text] [Related]
12. Breast cancer pseudometastasis in a sentinel lymph node with cytokeratin-positive debris. Rao RS; Taylor J; Palmer J; Jennings WC Breast J; 2005; 11(2):134-7. PubMed ID: 15730460 [TBL] [Abstract][Full Text] [Related]
13. Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in node-negative endometrial cancer. Yabushita H; Shimazu M; Yamada H; Sawaguchi K; Noguchi M; Nakanishi M; Kawai M Gynecol Oncol; 2001 Feb; 80(2):139-44. PubMed ID: 11161851 [TBL] [Abstract][Full Text] [Related]
14. Cytokeratin-positive interstitial reticulum cells in the lymph node: A potential pitfall. Jacob PM; Nair RA; Nair SP; Jayasudha AV Indian J Pathol Microbiol; 2016; 59(1):128-9. PubMed ID: 26960661 [No Abstract] [Full Text] [Related]
15. Staining of sentinel node reticulum cells with cytokeratin antibody AE3. Yeh IT; Miller AR Arch Pathol Lab Med; 2002 Mar; 126(3):248-9. PubMed ID: 11860293 [No Abstract] [Full Text] [Related]
16. Ovarian low-grade serous carcinoma involving the cervix mimicking a cervical primary. Malpica A; Deavers MT Int J Gynecol Pathol; 2011 Nov; 30(6):613-9. PubMed ID: 21979600 [TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical comparative investigations of lymphatic tissue in reactive processes, myasthenic thymuses and Hodgkin's disease. Zółtowska A Arch Immunol Ther Exp (Warsz); 1995; 43(1):15-22. PubMed ID: 8744679 [TBL] [Abstract][Full Text] [Related]
18. Clear-Cell Atypical Fibroxanthoma: A Combined Immunohistochemistry Analysis. Brau Javier CN; Valentín Colón DC; Sánchez JL; Sánchez JE Am J Dermatopathol; 2016 Oct; 38(10):775-9. PubMed ID: 26959699 [TBL] [Abstract][Full Text] [Related]
19. Cutaneous manifestations of angioimmunoblastic T-cell lymphoma: clinical and pathological characteristics. Botros N; Cerroni L; Shawwa A; Green PJ; Greer W; Pasternak S; Walsh NM Am J Dermatopathol; 2015 Apr; 37(4):274-83. PubMed ID: 25794369 [TBL] [Abstract][Full Text] [Related]
20. Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains. Tamas EF; Epstein JI Am J Surg Pathol; 2007 Mar; 31(3):390-7. PubMed ID: 17325480 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]